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Abstract: Bioactive compounds were detected in crude extracts of the fungus, 
Calcarisporium sp. KF525, which was isolated from German Wadden Sea water samples. 
Purification of the metabolites from the extracts yielded the five known polyesters, 
15G256α, α-2, β, β-2 and π (1–5), and five new derivatives thereof, named calcarides A–E 
(6–10). The chemical structures of the isolated compounds were elucidated on the basis of 
one- and two-dimensional NMR spectroscopy supported by UV and HRESIMS data. The 
compounds exhibited inhibitory activities against Staphylococcus epidermidis, 
Xanthomonas campestris and Propionibacterium acnes. As the antibacterial activities were 
highly specific with regard to compound and test strain, a tight structure-activity 
relationship is assumed. 
Keywords: fungal natural products; Calcarisporium sp.; calcarides A–E; 15G256 




NMR, nuclear magnetic resonance; HRESIMS, high-resolution electrospray ionization mass 
spectrometry; HPLC, high-performance liquid chromatography; MS, mass spectrometry; ESIMS, 
electrospray ionization mass spectrometry; DEPT, distortionless enhancement by polarization transfer; 
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COSY, correlation spectroscopy; HSQC, heteronuclear single-quantum coherence; HMBC, 
heteronuclear multiple bond correlation; Mult., multiplicity; ESI, electrospray ionization; calcd, 
calculated; SI, supplementary information; OD600, optical density at 600 nm; DMSO, dimethyl 
sulfoxide; PYG medium, peptone yeast glucose medium; DSMZ, German collection of 
microorganisms and cell cultures. 
1. Introduction 
Fungal species of the genus, Calcarisporium, have a widespread occurrence and are frequently 
found as mycoparasites or symbiotes of higher fungi [1–5]. The Calcarisporium sp. strain KF525 
investigated in this study was isolated from a water sample taken in the German Wadden Sea. It 
showed a diverse chemical profile, including ten structurally closely related compounds of the 
15G256-type known as, e.g., 15G256α (1) or α-2 (2) (Figure 1; to be differentiated from the structural 
class comprising 15G256γ, δ and ε). 
Figure 1. Compounds isolated from Calcarisporium sp. KF525: 15G256α, α-2, β, β-2 and 
π (1–5) and calcarides A–E (6–10). 
 
The 15G256-type compounds are produced by a number of fungi, such as ascomycetes, like 
Hypoxylon, Penicillium, Talaromyces, Acremonium and Scedosporium species, as well as by the 
basidiomycete, Albatrellus confluens [6–12]. Since some metabolites were isolated independently from 
the different producer strains, renaming occurred among the 15G256-type compounds. 15G256α (1)  
is synonymous with BK233-A and NG-012, 15G256α-1 is a synonym of BK233-B and probably  
NG-011 (discussed in [6]), while 15G256β (3) was also named orbuticin, BK233-C and  
BE-26263 [6,7,9,10,13]. With regard to the chemical structures, the compounds are polyesters that 
occur either in closed ring structures as macrocycles or as linear molecules (Figure 1). Schlingmann et al. 
proposed a biosynthesis route in which 6-hydroxymellein and β-hydroxybutyric acid (Figure 2) are the 
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biosynthetic steps, the macrocyclic 15G256 compounds arise from the linear polyesters by ring closure 
reactions [6]. Various biological activities have been ascribed to the 15G256 agents, including 
antifungal, estrogenic and cytotoxic properties, as well as they were shown to potentiate nerve growth 
factor-induced neurite outgrowth [6–10]. For example, 15G256α (1), α-1 and β (3) attracted attention 
in the field of crop protection, as they displayed antifungal properties against important plant 
pathogenic fungi, e.g., Botrytis cinerea or Monilinia fructigena [7]. 
Here, we report the isolation of five known (1–5) and five new (6–10) 15G256-type compounds from 
Calcarisporium sp. strain KF525. Their structure elucidation and antibacterial activities are described. 
Figure 2. Proposed biosynthetic precursors of the calcarides (based on the proposal of 
Schlingmann et al. [6]). 
 
2. Results and Discussion 
2.1. Isolation and Structure Elucidation 
The fungal strain KF525 is a Calcarisporium sp. that is a part of the marine fungal strain collection 
of the Kiel Center for Marine Natural Products [14]. Extracts of cultures from the Calcarisporium sp. 
strain KF525 grown in modified casamino acids glucose medium [15] showed antibacterial activities 
and were investigated in detail. Fractionation of these extracts by preparative reversed-phase HPLC 
yielded the known compounds, 15G256α, α-2, β, β-2 and π (1–5), as well as five new derivatives 
thereof, calcarides A–E (6–10) (Figure 1). 
The structures of 1–5 were identified by comparison of their spectroscopic data (UV, MS and  
1
H NMR spectra) with those described in the literature [6]. As the data agreed well with the values 
published, the structures of 1–5 were assigned as shown in Figure 1. 
The molecular formula of calcaride A (6) was determined to be C33H40O14 by high-resolution 
ESIMS measurements (measured 661.2503, calculated 661.2491 [M + H]
+
). The structure of 6 was 




C, DEPT, COSY, HSQC and 
HMBC, see Table 1). The NMR spectra of 6 were measured in acetone-d6, as it did not dissolve well in 
methanol-d4, whereas NMR data of all other calcarides were recorded in methanol-d4. The analysis of 
the NMR data of 6 revealed considerable structural similarities with 15G256β (3). The 1H NMR 
spectrum, the 
1
H NMR coupling constants and the 
13
C NMR spectrum of 6 showed that, comparable to 
3 [6,7], the compound was composed of two phenyl moieties with their two protons in meta position to 
each other and five methyl, five methylene, five methine and five ester carbonyl groups. The  
two-dimensional NMR spectra of 6 proved that the aforementioned functional groups were connected 
exactly as in 3, forming a cyclic pentalactone. A mass difference of 14 between 6 and 3 indicated the 
presence of an additional methyl group in 6, which was corroborated by additional signals for a methyl 
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resonances (δH 3.82 ppm, δC 55.8 ppm) determined it to be a methoxy group. The proton signal of the 
methoxy group correlated with C-9 in the HMBC NMR spectrum. Thus, the structure of 6 was 
identified as the methylated derivative of 3, with the methyl group attached to the hydroxyl group of C-9. 
Table 1. NMR spectroscopic data (500 MHz, acetone-d6) of calcaride A (6). 
Position δC, Type δH, Mult. (J in Hz) COSY HMBC 
1 170.09, C       
2a 40.6, CH2 2.91, dd (6.7, 16.3) 2b, 3 1, 3, 4 
2b  2.74, dd (6.4, 16.3) 2a, 3 1, 3, 4 
3 70.1, CH 
a
 5.56, m 2a, 2b, 4 1, 2, 4, 5 
4 20.0, CH3 1.450, d (6.4) 3 1, 2, 3 
5 171.0, C    
6 106.9, C    
7 165.5, C    
8 100.4, CH 6.36, d (2.6) 10 5, 6, 7, 9, 10 
9 164.8, C    
OCH3 55.8, CH3 3.82, s  9 
10 111.9, CH 6.44, d (2.6) 8 5, 6, 8, 9, 12 
11 142.9, C    
12a 41.7, CH2 3.547, dd (6.8, 13.3) 12b, 13 6, 10, 11, 13, 14 
12b  2.98, dd (7.5, 13.3) 12a, 13 6, 10, 11, 13, 14 
13 73.1, CH 5.05, m 
b
 12a, 12b, 14 11, 12, 14, 15 
14 19.7, CH3 1.19, d (6.2) 13 12, 13 
15 170.12, C    
16a 41.02, CH2 2.90, dd (6.3, 15.8) 16b, 17 15, 17, 18 
16b  2.72, dd (7.1, 15.8) 16a, 17 15, 17, 18 
17 70.0, CH 
a
 5.52, m 16a, 16b, 18 15, 16, 18, 19 
18 20.1, CH3 1.454, d (6.4) 17 15, 16, 17 
19 170.9, C    
20 105.6, C    
21 165.9, C    
22 102.6, CH 6.30, d (2.5) 24 19, 20, 21, 23, 24 
23 163.1, C    
24 113.3, CH 6.35, d (2.5) 22 19, 20, 22, 23, 26 
25 143.3, C    
26a 42.4, CH2 3.553, dd (5.7, 12.9) 26b, 27 20, 24, 25, 27, 28 
26b  2.78, dd (8.6, 12.9) 26a, 27 20, 24, 25, 27, 28 
27 72.5, CH 5.01, m 
b
 26a, 26b, 28 25, 26, 28, 29 
28 19.5, CH3 1.14, d (6.2) 27 26, 27 
29 170.2, C    
30a 41.01, CH2 2.63 
c 
30b, 31 29, 31, 32 
30b  2.63 
c 
30a, 31 29, 31, 32 
31 68.4, CH 5.28, m 30a, 30b, 32 1, 29, 30, 32 
32 19.9, CH3 1.27, d (6.3) 31 29, 30, 31 
a
 Assignments of C-3 and C-17 are interchangeable; 
b
 signals overlap and are deduced from the HSQC NMR 
spectrum; 
c
 signals overlap. 
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The molecular formula of calcaride B (7) was deduced to be C33H40O15 by high-resolution ESIMS 
measurements (measured 677.2435, calculated 677.2440 [M + H]
+
). UV and NMR spectra of 7  
(Tables 2 and 3) strongly resembled those of 6. The NMR spectra of 7 showed all resonances as those 
of 6, apart from one striking difference: the signals in position 32 corresponded to a methylene instead 
of a methyl group. The downfield shift of the proton and carbon signals of CH2-32 (δH 3.65 and  
3.58 ppm, δC 63.6 ppm) suggested the attachment of a hydroxyl group to C-32 in 7. This was in full 
accordance with a mass increase of 16 mass units in comparison to 6 and determined 7 to be the 
methylated analog of the known compound, 15G256α (1). 
Table 2. 
1
H NMR spectroscopic data of calcarides A–C (6–8) (500 MHz, acetone-d6 for 6; 
500 MHz, methanol-d4 for 7–8). 
  Calcaride A (6) Calcaride B (7) Calcaride C (8) 
Position δH, Mult. (J in Hz) δH, Mult. (J in Hz) δH, Mult. (J in Hz) 
2a 2.91, dd (6.7, 16.3) 2.88, dd (7.7, 16.6) 2.878, dd (8.1, 16.2) 
2b 2.74, dd (6.4, 16.3) 2.73, d (5.3, 16.6) 2.79, dd (4.8, 16.2) 
3 5.56, m 5.56, m 5.59, m 
4 1.450, d (6.4) 1.42, d (6.3) 1.44, d (6.4) 
8 6.36, d (2.6) 6.30, d (2.6) 6.31, d (2.6) 
OCH3 3.82, s 3.75, s 3.74, s 
a
 
10 6.44, d (2.6) 6.36, d (2.6) 6.35, d (2.6) 





12b 2.98, dd (7.5, 13.3) 2.96, dd (6.4, 13.8) 2.99, dd (6.6, 14.0) 
13 5.05, m 
d
 5.07, m 5.16, m 
14 1.19, d (6.2) 1.20, d (6.2) 1.22, d (6.2) 
16a 2.90, dd (6.3, 15.8) 2.81, dd (7.6, 15.8) 2.85, dd (6.6, 16.0) 
16b 2.72, dd (7.1, 15.8) 2.67, dd (5.7, 15.8) 2.69, dd (6.6, 16.0) 
17 5.52, m 5.49, m 5.48, m 
18 1.454, d (6.4) 1.40, d (6.4) 1.39, d (6.3) 
22 6.30, d (2.5) 6.22, s 6.21, d (2.5) 
24 6.35, d (2.5) 6.22, s 6.23, d (2.5) 





26b 2.78, dd (8.6, 12.9) 2.77, dd (8.1, 13.3) 2.885, dd (6.9, 13.4) 
27 5.01, m 
d
 4.98, m 5.03, m 
28 1.14, d (6.2) 1.11, d (6.2) 1.16, d (6.2) 
30a 2.63 
e 
2.68, dd (5.1, 16.7) 2.51, dd (6.0, 15.3) 
30b 2.63 
e 
2.64, dd (8.1, 16.7) 2.43, dd (7.2, 15.3) 
31 5.28, m 5.28, m 4.17, m 
32a 1.27, d (6.3) 3.65, dd (4.5, 11.9) 4.12, dd (4.8, 11.1) 
32b   3.58, dd (5.1, 11.9) 4.08, dd (5.5, 11.1) 
a 
Position of the methoxy group could not unambiguously be determined. In analogy to the other calcarides, it 
was assumed to be linked to C-9. 
b
 Signal partially obscured and deduced from the HMBC NMR spectrum;  
c
 signal partially obscured; 
d
 signals overlap and are deduced from the HSQC NMR spectrum; 
e
 signals overlap. 
Calcaride C (8) was found to have a molecular formula of C33H40O15 by means of high-resolution 
ESIMS measurements (measured 677.2441, calculated 677.2440 [M + H]
+
). Thus, 7 and 8 had the 
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same molecular formula, showing that the closely related compounds were structural isomers, as was 
confirmed by comparison of the NMR spectra of the two compounds (Tables 2 and 3). For two of the 
known 15G256 components, 15G256α (1) and 15G256α-1 (Figure 3), a comparable regioisomerism 
was observed in which either β- or γ-hydroxyester linkages lead to the ring closure of the compound [6]. 
Table 3. 
13
C NMR shifts of calcarides A–E (6–10) (125 MHz, acetone-d6 for 6; 125 MHz, 
methanol-d4 for 7–9; 150 MHz, methanol-d4 for 10). 
  Calcaride A (6) Calcaride B (7) Calcaride C (8) Calcaride D (9) Calcaride E (10) 
Position δC δC δC δC δC 
1 170.09 171.5 
a





2 40.6 41.0 41.2 41.8 43.3 
3 70.1 
c
 70.2 70.5 70.8 71.5 
4 20.0 20.2 20.2 20.1 20.3 







6 106.9 108.7 108.2 107.2 107.3 







8 100.4 100.7 100.7 100.8 100.8 







OCH3 55.8 55.8 55.8 
k
 55.9 55.9 
10 111.9 111.5 111.3 112.8 112.8 
11 142.9 142.6 142.7 143.2 143.3 
12 41.7 41.8 41.7 43.2 43.4 
13 73.1 73.6 73.2 73.1 73.2 
14 19.7 20.0 20.0 20.52 20.6 




 171.2 171.2 
16 41.02 41.6 41.6 
l
 41.8 41.8 
17 70.0 
c
 70.4 70.3 70.0 70.0 
18 20.1 20.2 20.1 19.9 19.9 







20 105.6 106.7 107.3 105.8 105.7 
21 165.9 165.4 165.14 
g
 166.2 166.3 
22 102.6 102.8 102.7 102.7 102.7 
23 163.1 163.5 163.4 163.5 163.6 
24 113.3 113.3 112.6 113.8 113.9 
25 143.3 143.2 143.1 143.7 143.7 
26 42.4 42.3 41.5 
l
 43.5 43.6 
27 72.5 73.5 73.6 72.7 72.6 
28 19.5 19.5 19.8 20.49 20.6 
29 170.2 171.43 
a
 171.9 172.7 172.5 
30 41.01 36.7 40.4 39.9 45.1 
31 68.4 72.7 67.1 69.9 65.4 






 Assignments are interchangeable; 
b
 Signal deduced from the HMBC NMR spectrum; 
k
 Position of the 
methoxy group could not unambiguously be determined. In analogy to the other calcarides it was assumed to 
be linked to C-9. 
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Figure 3. Structure of 15G256 α-1 [6].  
 
Given that 7 is the methylated form of 1, it was assumed that 8 was the methylated derivative of 
15G256α-1. The NMR spectra of 8 confirmed the assumption, since the signals were in good 
agreement with those reported for 15G256α-1 [6]. An additional resonance for a methoxy group in the 
NMR spectra of 8 determined it to be the methyl ether of 15G256α-1. As the assignments of C-7  
(δC 165.08 ppm) and C-9 (δC 165.0 ppm) might be interchangeable, the position of the methoxy group 
that showed a correlation to either of the two signals in the HMBC spectrum could not unambiguously 
be determined. In analogy to 6, 7, 9 and 10, where the methyl group was linked to the hydroxyl group 
of C-9, it was deduced that this is also most likely to be the case for compound 8. In addition to being 
regioisomers, it was observed that 7 and 8 interconverted during storage as dried compounds, with 7 
showing a purity of about 75% after a period of two weeks. At the same time, compound 8 had 
converted into 7 more slowly and showed a purity of around 85%. These percentages were stable over 
a period of three months in which the compound stability was studied. 
The molecular formula of calcaride D (9) was determined as C33H42O16 on the basis of  
high-resolution ESIMS measurements (measured 693.2405, calculated 693.2400 [M − H]−), requiring 
13 degrees of unsaturation. The NMR spectra of 9 (Tables 3 and 4) showed signals for the two 
phenolic substructures characteristic of the calcarides and five carbonyl resonances, together 
accounting for 13 double bond equivalents. These data suggested a ring opening for 9, giving the 
structure of a linear polyester, as has been found among the 15G256 components, as well, e.g., 
15G256α-2 (2), β-2 (4) and π (5). MS and NMR spectra proved 9 to be the methylated analog of 2. For 
the linear calcarides (9 and 10), the NMR spectra recorded in methanol-d4 gave one single signal for 
the aromatic protons of H-8 and H-10 (δH 6.33 ppm). Therefore, the position of the carbon signals of 
C-7 and C-9 (δC 166.0 and 165.0 ppm) could not be differentiated by the HMBC correlations of the 
aromatic protons resonances. As a consequence, the methoxy group showing a clear HMBC 
correlation to the signal at 165.0 ppm could have been attached to either C-7 or C-9. In order to 
determine the position of the methoxy group of 9, additional NMR spectra were recorded in 
chloroform-d1 in which signals of H-8 and H-10 appeared separately. The HMBC NMR spectrum 
displayed correlations of H-8 to C-7 and C-9 and of H-10 to C-9 and C-12. Thereby, the positions of the 
signals for C-7 and C-9 could be assigned. Consequently, the methoxy group for which the HMBC 









OH   





H NMR spectroscopic data of calcarides D and E (9 and 10) (500 MHz, 
methanol-d4 for 9; 600 MHZ, methanol-d4 for 10). 
  Calcaride D (9) Calcaride E (10) 
Position δH, Mult. (J in Hz) δH, Mult. (J in Hz) 
2a 2.767, dd (7.5, 15.8) 2.72, dd (7.8, 15.4) 
2b 2.69, dd (5.3, 15.8) 2.61, dd (5.9, 15.4) 
a
 
3 5.57, m 5.58, m 
4 1.43, d (6.4) 1.43, d (6.3) 
8 6.33, s 6.33, s 
OCH3 3.77, s 3.77, s 
10 6.33, s 6.33, s 
12a 3.29 
b
 3.35, dd (3.5, 13.6) 
a
 
12b 2.91, dd (9.7, 13.7) 2.87, dd (9.8, 13.6) 
13 5.22, m 5.22, m 
14 1.25, d (6.2) 1.26, d (6.3) 
16a 2.66, dd (7.2, 15.7) 2.65, dd (7.2, 15.6) 
16b 2.62, dd (5.8, 15.7) 2.62, dd (6.0, 15.6) 
17 5.47, m 5.47, m 
18 1.30, d (6.4) 1.30, d (6.3) 
22 6.203, d (2.6) 6.19, d (2.5) 
24 6.197, d (2.6) 6.18, d (2.5) 
26a 3.17, dd (4.0, 13.4) 3.20, dd (3.8, 13.5) 
26b 2.772, dd (9.2, 13.4) 2.74, dd (9.5, 13.5) 
27 5.15, m 5.14, m 
28 1.23, d (6.2) 1.23, d (6.2) 
30a 2.47, dd (5.2, 15.4) 2.36, dd (6.9, 14.7) 
30b 2.27, dd (7.9, 15.4) 2.26, dd (6.5, 14.7) 
31 3.94, m 4.02, m 
32a 3.44, dd (4.9, 11.2) 1.05, d (6.2) 
32b 3.40, dd (5.7, 11.2)   
a
 Signal partially obscured; 
b
 signal partially obscured and is deduced from the HSQC NMR spectrum. 
The molecular formula of calcaride E (10) was determined to be C33H42O15 by high-resolution 
ESIMS measurements (measured 677.2467, calculated 677.2451 [M − H]−). The structure of 10 was 
readily deduced by comparing the NMR data (Tables 3 and 4) with those of 9. In contrast to the 
hydroxylated methylene group at C-32 in 9, the corresponding signals in the NMR spectra of 10 gave 
evidence for a methyl group not adjacent to oxygen. The position of the methoxy group at C-9 was 
determined according to additionally recorded NMR spectra in chloroform-d1, as described for 9. 
Hence, the structure of 10 was established as the dehydroxylated form of 9, which could equivalently 
be described as the methylated analog of 4. 
Because 6–10 were methylated forms of known compounds, it had to be ruled out that they were 
artifacts arising from the extraction protocol employing methanol as the solvent. The first indication 
that this was not the case for 6–10 was that the four demethylated analogs 1–4, which were, as well, 
isolated from Calcarisporium sp. KF525, stayed demethylated when stored as methanolic solutions for 
time periods of more than two weeks. The final proof was that the isolation of 6–10 was likewise 
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possible, when the use of methanol was avoided in all extraction steps and acetonitrile was employed 
instead. For this purpose, the presence of 6–10 was confirmed by using HPLC-UV/MS fingerprints of 
extracts from methanol and acetonitrile. 
Absolute configurations of 6–10 were investigated by measurements of the optical rotation. The 
obtained values for optical activity were compared to those described for the demethylated analogs. 
The optical rotation data of 6–8 ([α]22D −23.6, −25.3 and −7.9, respectively) were in good agreement 
with the reported ones of the corresponding demethylated forms, 3, 1 and 15G256α-1 [6–9]. Even 
though some of the published values referred to ethanol solutions or higher temperatures employed for 
the measurements, they were consistent with our data. Hence, the absolute configurations of 6–8 were 
suggested to be the same as for their published demethylated forms [6]. For 2 and 4, which are the 
demethylated derivatives of 9 and 10, there is no literature record of optical rotation values. Thus, a 
comparison with published data was not possible, but as 2 and 4 were also isolated from 
Calcarisporium sp. KF525, their optical rotation was measured ([α]22D −77.8 for 2; [α]
22
D −76.9 for 4) 
and compared with the values of 9 and 10 ([α]22D −71.8 and −67.3, respectively). As a result, the 
stereochemistry of 9 and 10 was assumed to be identical to the stereochemistry for 2 and 4 proposed 
by Schlingmann et al. [6] (Figure 1). 
From a biosynthetic perspective, the precursors of the known 15G256 components are  
6-hydroxymellein and β-hydroxybutyric acid [6]. Consequently, the building blocks of the calcarides 
should be 6-methoxymellein additional to 6-hydroxymellein and β-hydroxybutyric acid (Figure 2).  
6-methoxymellein is a natural product known from a variety of fungi, e.g., Aspergillus and 
Ceratocystis species [16]. Both, 6-methoxy- and 6-hydroxy-mellein were found in crude extracts of 
Calcarisporium sp. KF525, according to UV and MS spectra from analytical HPLC-UV/MS analyses. 
The position of the methoxy and hydroxyl groups in the mellein structure could not be deduced from 
these data and was only assumed according to the position of the respective groups in the calcarides. 
Given that the calcarides are built up by the same or methylated precursors as the 15G256 components, 
the identical stereochemistry in calcaride and 15G256 molecules is reasonable. 
2.2. Antibacterial Activity 
Compounds 1–10 were profiled against a set of bacterial strains, including the biofilm-forming, 
Staphylococcus epidermidis, the plant pathogen, Xanthomonas campestris, and Propionibacterium 
acnes, which is linked to the skin disease acne. Even though the compounds are closely related from a 
structural point of view, they show distinct antibacterial activities (Table 5). All macrocyclic 
compounds (1, 3, 6–8) inhibited S. epidermidis and X. campestris, while the linear polyesters did not 
show any activities below a minimal inhibitory concentration (MIC) of 100 µM. The results indicated 
that a ring structure is required for the activity. This observation was also made for antifungal 
properties of the already known 15G256 components [6]. Among the cyclic compounds, 1 showed the 
highest activity against S. epidermidis ((12.9 ± 3.6) µM), and 6 displayed the lowest MIC for  
X. campestris ((5.5 ± 1.3) µM). A comparison of the inhibition between active methylated and 
demethylated forms, e.g. 1 and 7 or 3 and 6, showed a decreased activity against S. epidermidis by a 
factor of four for the methylated analogs, whereas the activities concerning X. campestris were in the 
same concentration range. P. acnes was not inhibited by any of the tested substances, but the linear 
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compound 5. Given that 5 and 4 only differ in a β-hydroxybutyrate moiety, the P. acnes-related 
activity of 5 seemed highly specific. 
Table 5. Antibacterial minimal inhibitory concentrations (MICs) of compounds 1–10 and 
the positive control, chloramphenicol. Activities higher than 20% were considered  
as inhibitory. 
Compound 
S. epidermidis  
MIC [µM] 
X. campestris  
MIC [µM] 
P. acnes  
MIC [µM] 
15G256α (1) 12.9 (±3.6) 30.8 (±3.1) >100 
15G256α-2 (2) >150 >150 >200 
15G256β (3) 16.9 (±0.6) 14.9 (±7.5) >200 
16G256β-2 (4) >150 >150 >100 
15G256π (5) >150 >150 14.1 (±1.8) 
calcaride A (6) 68.8 (±3.7) 5.5 (±1.3) >200 
calcaride B (7) 52.3 (±2.3) 22.6 (±9.2) >200 
calcaride C (8) 29.6 (±1.6) 61.4 (±12.7) >100 
calcaride D (9) >150 >150 >200 
calcaride E (10) 104.3 (±7.8) >150 >100 
chloramphenicol 4.5 1.0 0.5 
15G256 components are known to possess antifungal activities, estrogenic effects or cytotoxic 
properties with regard to cellular ATP (viability) and chemiluminescence (phagocytosis) in a mouse 
peritoneal macrophage assay, as well as they are described to be potentiators of the nerve growth 
factor in PC12 cells [6–10]. However, no antibacterial activities had been observed, even when tested. 
Here, the 15G256 compounds and the new methylated derivatives thereof were found to display 
antibacterial activities that are moderate in potency, but have a tight structure-activity relationship. 
Even a slight structural variation, like a methylation, as seen for the calcarides, influenced compound 
activities significantly. This was found to be true for other natural products [17,18]. For instance, the 
methylation of the cholesterol-lowering agent, lovastatin, resulted in the improved drug, simvastatin [19]. 
Regarding simvastatin, the introduction of a methyl group was used as a tool, but similarly, the 
isolation of derivatives of known compounds can be used as a strategy to obtain improved lead 
structures. As shown for the calcarides, fungi are a good source for this purpose, because they often 
produce a bunch of structurally related compounds, e.g., resulting from the promiscuity of the 
biosynthetic enzymes [20]. From the fungus’ point of view, the production of closely-related 
components might be of advantage as altered activities emerge. 
3. Experimental Section 
3.1. General Experimental Procedures 
Optical rotation measurements were obtained on a Perkin Elmer model 241 polarimeter. UV spectra 
were measured on a Perkin Elmer Lambda 2 photometer. NMR spectra were recorded on a Bruker 




C NMR, respectively) and a Bruker AV 600 spectrometer 




C NMR, respectively). The residual solvent signals were used as 
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internal references for NMR analyses (δH 3.31 and δC 49.0 ppm for methanol-d4; δH 2.05 and  
δC 29.8 ppm for acetone-d6, δH 7.26 and δC 77.2 ppm for chloroform-d1). High-resolution mass spectra 
were measured with a Bruker micrOTOF II, applying positive or negative ESI mode. Analytical  
reversed-phase HPLC-UV/MS experiments were conducted on a VWR-Hitachi LaChrom Elite system 
equipped with an L-2130 pump, an L-2450 diode array detector, an L-2200 autosampler, an L-2300 
column oven and a Phenomenex Onyx Monolithic column (C18, 100 × 3.00 mm). A gradient with 
0.1% formic acid in H2O (A) and 0.1% formic acid in acetonitrile (B) as solvents was applied: 0 min 
5% B, 4 min 60% B, 6 min 100% B; flow 2 mL min
−1
. For mass detection, the analytical HPLC 
system was coupled to a Bruker esquire4000 ion-trap detector. Preparative HPLC was performed on a 
VWR LaPrep system consisting of a P110 pump, a P311 UV detector, a Labocol Vario-2000 fraction 
collector (LABOMATIC), a Smartline 3900 autosampler (Knauer) and a Phenomenex Gemini-NX 
column (10 μ C18, 100A, Axia, 100 × 50.00 mm). Subsequent compound purifications were performed 
on a Merck-Hitachi LaChrom Elite HPLC system comprised of an L-7150 pump, an L-2450 diode array 
detector and an L-2200 autosampler employing a reversed-phase Phenomenex Gemini-NX column  
(5 μ C18, 110A, Axia, 100 × 21.20 mm). 0.1% of formic acid in H2O (A) and 0.1% formic acid in 
acetonitrile (B) were the solvents used in preparative HPLC separations. 
3.2. Fungal Material 
Calcarisporium sp. KF525 is a part of the marine fungal strain collection of the Kiel Center for 
Marine Natural Products. The strain was cryo-conserved using the Microbank system (Pro-Lab). 
3.3. Cultivation 
Calcarisporium sp. KF525 was cultivated in 12 L of casamino acids glucose medium  
(0.25% casein hydrolysate, 4% glucose × H2O, 0.01% MgSO4 × 7H2O, 0.18% KH2PO4, pH 6.8) [15]. 
2-L Erlenmeyer flasks filled with 0.75 L medium were used for the culture experiments, which were 
performed for 24 days at 22 °C under shaking conditions (120 rpm) in the dark. A circular agar slant 
(1.8 cm in diameter) of a preculture served as the inoculum. The preculture was grown on agar plates 
of modified Wickerham medium (0.3% malt extract, 0.3% yeast extract, 0.5% peptone from soymeal, 
1% glucose × H2O, 3% NaCl, 1.5% agar, pH 6.25) [21] over a period of 11 days at room temperature 
in the dark. 
3.4. Isolation Procedure 
The cultures of Calcarisporium sp. KF525 were separated into mycelium and culture supernatant. 
An extraction of the culture supernatant with EtOAc yielded a crude extract of 0.92 g. The extract was 
subjected to the first purification step using a VWR LaPrep HPLC system (gradient: 0 min 10% B,  
17 min 60% B, 22 min 100% B; flow 100 mL min
−1
; UV detection at 217 nm). The purification gave  
8 fractions containing the 15G256 and calcaride components (tR 12.4, 13.2, 14.5, 15.7, 16.2, 17.6, 18.5 
and 20.6 min) of which fraction 8 comprised pure 6 in a yield of 17.7 mg. All other fractions were 
further purified on a Merck-Hitachi LaChrom Elite HPLC system applying reversed-phase 
chromatography. The purification of fraction 1 gave 17.8 mg of 2 (gradient: 0 min 30% B, 13 min 
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40% B; flow 18 mL min
−1
; UV detection at 220 nm; tR 6.7 min) and fraction 2 afforded 11.8 mg of 5 
(gradient: 0 min 25% B, 13 min 50% B; flow 18 mL min
−1
; UV detection at 220 nm; tR 9.2 min). The 
chromatography of fraction 3 (gradient: 0 min 30% B, 15 min 37% B; flow 18 mL min
−1
; UV 
detection at 220 nm) resulted in 14 mg of purified 4 (tR 11.1 min) and semi-pure 9 (tR 12.0 min), which 
was isolated in two additional rounds of purification to give a yield of 23.2 mg (1st, gradient: 0 min 
30% B, 13 min 45% B; flow 18 mL min
−1
; UV detection at 220 nm; tR 9.2 min. 2nd, isocratic: 25% B; 
flow 18 mL min
−1
; UV detection at 210 nm; tR 23.2 min). Pure 1 (17.5 mg) was obtained from fraction 4 
by applying two consecutive steps of preparative HPLC (1st, 0 min 40% B, 13 min 65% B, flow  
18 mL min
−1
; UV detection at 205 nm; tR 5.2 min. 2nd, gradient: 0 min 30% B, 10 min 61% B; flow  
18 mL min
−1
; UV detection at 220 nm; tR 7.6 min). Fraction 5 was subjected to two further purification 
steps yielding 2.9 mg of 10 (1st, isocratic: 29% B, flow 18 mL min
−1
; UV detection at 220 nm;  
tR 21.7 min. 2nd, gradient: 0 min 27% B, 15 min 50% B; flow 18 mL min
−1
; UV detection at 220 nm;  
tR 12.4 min). Fraction 6 contained compounds 7 and 8, which were initially eluted isocratically with 
42% B (flow 18 mL min
−1
; UV detection at 220 nm; tR 11.8 min). A subsequent round of preparative 
HPLC (isocratic: 40%, flow 18 mL min
−1
; UV detection at 210 nm) gave purified 7 (tR 12.8 min) and 8 
(tR 16.0 min) in yields of 14.6 and 5.7 mg, respectively. 1.8 mg of compound 3 were isolated from 
fraction 7 by employing two chromatographic steps (1st, gradient: 0 min 50% B, 13 min 80% B; flow 
18 mL min
−1
; UV detection at 220 nm; tR 6.0 min. 2nd, isocratic: 45% B, flow 18 mL min
−1
; UV 
detection at 220 nm; tR 7.3 min.). 
Calcaride A (6): Pale yellow solid, [α]22D −23.6 (c 0.195, MeOH), UV (MeOH) λmax (log ε)  
216 (4.57), 263 (4.27), 302 (3.92) nm; for 1D and 2D NMR data see Table 1; HRESIMS m/z 661.2503 
[M + H]
+
 (calcd for C33H40O14, 661.2491). 
Calcaride B (7): White solid, [α]22D −25.3 (c 0.45, MeOH), UV (MeOH) λmax (log ε) 216 (4.58), 
263 (4.27), 302 (3.92) nm; for 1D and 2D NMR data see Tables 2, 3 and SI; HRESIMS m/z 677.2435 
[M + H]
+
 (calcd for C33H40O15, 677.2440). 
Calcaride C (8): White solid, [α]22D −7.9 (c 0.793, MeOH), UV (MeOH) λmax (log ε) 216 (4.59), 
263 (4.30), 302 (3.94) nm; for 1D and 2D NMR data see Tables 2, 3 and SI; HRESIMS m/z 677.2441 
[M + H]
+
 (calcd for C33H40O15, 677.2440). 
Calcaride D (9): White solid, [α]22D −71.8 (c 0.98, MeOH), UV (MeOH) λmax (log ε) 216 (4.60), 
263 (4.35), 302 (3.99) nm; for 1D and 2D NMR data see Tables 3, 4 and SI; HRESIMS m/z 693.2405 
[M − H]− (calcd for C33H42O16, 693.2400). 
Calcaride E (10): White solid, [α]22D −67.3 (c 0.05, MeOH), UV (MeOH) λmax (log ε) 216 (4.61), 
263 (4.35), 302 (3.98) nm; for 1D and 2D NMR data see Tables 3, 4 and SI; HRESIMS m/z 677.2467 
[M − H]− (calcd for C33H42O15, 677.2451). 
The process of interconversion of 7 and 8 was studied by periodical HPLC-UV/MS analyses using 
the mass chromatograms for quantification of the compounds’ purities. For the experiments, purified 
and dried 7 and 8 were stored at 4 °C over a time period of three months. 
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3.5. Antibacterial Assays 
Antibacterial assays were performed using the test strains, Staphylococcus epidermidis 
(DSM20044), Xanthomonas campestris (DSM 2405) and Propionibacterium acnes (DSM1897).  
S. epidermidis and X. campestris were cultivated in Trypticase soy broth (1.2% Trypticase Soy Broth, 
0.5% NaCl) overnight and diluted to an OD600 of 0.01–0.03. 10 mM DMSO solutions of the 
compounds were diluted with medium to gain desired test concentrations. 10.5 µL of the compound 
solutions and 200 µL of the respective test strain cell suspension were transferred into a 96-well 
microtiter plate. Microtiter plates with S. epidermidis were incubated for 5 h at 37 °C in the dark, while 
microtiter plates with X. campestris were incubated for 6 h at 28 °C in the dark. After the addition of 
10 µL of a resazurin solution as the detective reagent (0.2 mg mL
−1
 in phosphate-buffered saline), the 
incubation was continued for another 5–30 min. To evaluate cell viability, the reduction of resazurin to 
resorufin was determined by measuring the intensity of fluorescence at 560Ex/590Em in a Tecan Infinite 
M200 plate reader. 
P. acnes was grown anaerobically (Anaerocult A mini, Merck) in modified PYG medium (DSMZ 
medium 104) for 48 h at 37 °C in the dark. 2-day old cultures were diluted to an OD600 of 0.02. A 
volume of 200 µL of the cell suspension was transferred to a microtiter plate and mixed with 10.5 µL 
of the test compounds that were treated as described above. After an anaerobic incubation for 48 h at 
37 °C in the dark, 10 µL of bromocresol purple (1 mg mL
−1
) were added, and the acid production of  
P. acnes was determined by measuring the absorbance at 590 nm (reference 690 nm) using the Infinite 
M200 plate reader. 
The resulting values of the antibacterial assays were compared with a positive control (10 µM 
chloramphenicol for S. epidermidis or X. campestris and 1 µM chloramphenicol for P. acnes) and a 
negative control (no compound). Minimal inhibitory concentrations (MICs) were defined as more than 
20% inhibition of metabolic activity or acid production in the test strains compared to non-inhibited 
metabolism in the negative control. 
4. Conclusions 
Five known 15G256 components and five methylated analogs thereof were isolated from 
Calcarisporium sp. strain KF525: 15G256α, α-2, β, β-2, π (1–5) and calcarides A–E (6–10). For the 
first time, antibacterial properties were detected for this type of natural product. The compounds 
showed inhibitory bioactivities against Staphylococcus epidermidis, Xanthomonas campestris and 
Propionibacterium acnes, underlying a tight structure-activity relationship. 15G256α (1) displayed the 
strongest inhibition against S. epidermidis, with a MIC of (12.9 ± 3.6) µM, and calcaride A (6) 
exhibited the lowest MIC for X. campestris with (5.5 ± 1.3) µM. P. acnes was specifically inhibited by 
the compound, 15G256π (5), having a MIC of (14.1 ± 1.8) µM. 
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